Newly-appointed Clinical Cell Culture chief executive Bob Atwill believes the company’s more focused sales and marketing approach will ultimately reap benefits for long-suffering shareholders.

Newly-appointed Clinical Cell Culture chief executive Bob Atwill believes the company’s more focused sales and marketing approach will ultimately reap benefits for long-suffering shareholders.